Literature DB >> 19282818

In-hospital mortality among black patients admitted for hypertension-related disorders in Mbuji Mayi, Congo.

Jean-René M'Buyamba-Kabangu1, Rachel T Biswika, Lutgarde Thijs, Gilbert M Tshimanga, Francine M Ngalula, Tumba Disashi, Patrick K Kayembe, Tom Richart, Jean-René M'Buyamba-Kayamba, François B Lepira, Jan A Staessen.   

Abstract

BACKGROUND: As a consequence of hypertension, sub-Saharan Africa faces an epidemic of cardiovascular disease.
METHODS: We assessed in-hospital mortality among patients admitted for hypertension-related diseases to two city hospitals in Mbuji Mayi, Congo. On admission, we obtained anthropometric measurements, blood pressure, information on cardiovascular risk factors, and on the awareness and treatment of hypertension. We modeled the probability of death, using stepwise logistic regression.
RESULTS: Of 401 consecutive patients (mean age, 54.3 years; 129 women), 118 (29.4 %) were unaware of their hypertension. Among 283 aware patients (70.6%), 126 (44.5%) were untreated. Systolic/diastolic blood pressure on admission averaged 178/106 mm Hg. In addition to hypertension, 390 patients (97.3%) had other cardiovascular risk factors, including a creatinine clearance below 60 ml/min/1.73 m(2) in 47 subjects (11.7%). Over 15 days (median) of hospitalization, 89 deaths (22.2%) occurred. The multivariable-adjusted probability of death increased with systolic blood pressure (odds ratio (95% confidence interval) for +10 mm Hg, 1.43 (1.15-1.77); P < 0.01), body mass index (+5 kg/m(2), 2.40 (1.39-4.17); P < 0.01), being aware vs. unaware of hypertension (3.17 (1.52-6.61); P < 0.01), and being untreated (2.33 (1.12-4.76); P < 0.05), but it decreased with age (+10 years, 0.65 (0.46-0.92); P < 0.05) and higher creatinine clearance (+10 ml/min/1.73 m(2), 0.71 (0.61-0.82); P < 0.001).
CONCLUSIONS: The in-hospital mortality among African patients hospitalized for hypertension-related disorders in a Congolese provincial capital city is over 20%. These findings underscore that screening and treatment for hypertension and the prevention of cardiovascular disease should be placed much higher on the political agenda in sub-Saharan Africa.

Entities:  

Mesh:

Year:  2009        PMID: 19282818     DOI: 10.1038/ajh.2009.47

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  11 in total

1.  The Burden of Hypertension and Diabetes in an Emergency Department in Northern Tanzania.

Authors:  Julian T Hertz; Francis M Sakita; Preeti Manavalan; Deng B Madut; Nathan M Thielman; Blandina T Mmbaga; Catherine A Staton; Sophie W Galson
Journal:  Ethn Dis       Date:  2019-10-17       Impact factor: 1.847

2.  Admission and Inpatient Mortality of Hypertension Complications in Addis Ababa.

Authors:  Abayneh Birlie Zeru; Mikyas Arega Muluneh
Journal:  Integr Blood Press Control       Date:  2020-09-16

3.  Progress report on the first sub-Saharan Africa trial of newer versus older antihypertensive drugs in native black patients.

Authors:  Augustine N Odili; Birinus Ezeala-Adikaibe; Mouhamadou B Ndiaye; Benedict C Anisiuba; Marius M Kamdem; Chinwuba K Ijoma; Joseph Kaptue; Hilaire J Boombhi; Philip M Kolo; Elvis N Shu; Lutgarde Thijs; Jan A Staessen; Babatunde A Omotoso; Samuel Kingue; Serigne A Ba; Daniel Lemogoum; Jean-René M'Buyamba-Kabangu; Ifeoma I Ulasi
Journal:  Trials       Date:  2012-05-17       Impact factor: 2.279

4.  Predictors of non-adherence to antihypertensive medication in Kinshasa, Democratic Republic of Congo: a cross-sectional study.

Authors:  Aimée M Lulebo; Paulin B Mutombo; Mala A Mapatano; Eric M Mafuta; Patrick K Kayembe; Lisa T Ntumba; Alain N Mayindu; Yves Coppieters
Journal:  BMC Res Notes       Date:  2015-10-01

5.  Efficacy of newer versus older antihypertensive drugs in black patients living in sub-Saharan Africa.

Authors:  J R M'Buyamba-Kabangu; B C Anisiuba; M B Ndiaye; D Lemogoum; L Jacobs; C K Ijoma; L Thijs; H J Boombhi; J Kaptue; P M Kolo; J B Mipinda; C E Osakwe; A Odili; B Ezeala-Adikaibe; S Kingue; B A Omotoso; S A Ba; I I Ulasi; J A Staessen
Journal:  J Hum Hypertens       Date:  2013-06-27       Impact factor: 3.012

6.  Hypertensive retinopathy and its association with cardiovascular, renal and cerebrovascular morbidity in Congolese patients.

Authors:  Nelly N Kabedi; Jean-Claude Mwanza; François B Lepira; Tharcisse K Kayembe; David L Kayembe
Journal:  Cardiovasc J Afr       Date:  2014 Sep-Oct       Impact factor: 1.167

7.  The misuse of Cyproheptadine: a non-communicable disease risk behaviour in Kinshasa population, Democratic Republic of Congo.

Authors:  Aimée M Lulebo; Carine D Bavuidibo; Eric M Mafuta; Josaphat D Ndelo; Lievin's Corneille M Mputu; Dalton M Kabundji; Paulin B Mutombo
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-02-09

8.  Prevalence and determinants of use of complementary and alternative medicine by hypertensive patients attending primary health care facilities in Kinshasa, Democratic Republic of the Congo: a cross-sectional study.

Authors:  Aimée M Lulebo; Mala A Mapatano; Paulin B Mutombo; Eric M Mafuta; Gédéon Samba; Yves Coppieters
Journal:  BMC Complement Altern Med       Date:  2017-04-08       Impact factor: 3.659

9.  May Measurement Month 2019: an analysis of blood pressure screening results from the Democratic Republic of the Congo.

Authors:  Jean-René M'Buyamba-Kabangu; Fortunat K Katamba; Mireille L Ntambwe; Georges N Ngoyi; Trésor M Tshiswaka; Pascal M Bayauli; Yves N Lubenga; Serge M Kazadi; Thomas Beaney; Xin Xia; Neil R Poulter; Nathan B Buila
Journal:  Eur Heart J Suppl       Date:  2021-05-20       Impact factor: 1.803

10.  Assessment of hypertension management in primary health care settings in Kinshasa, Democratic Republic of Congo.

Authors:  Aimée M Lulebo; Mala A Mapatano; Patrick K Kayembe; Eric M Mafuta; Paulin B Mutombo; Yves Coppieters
Journal:  BMC Health Serv Res       Date:  2015-12-24       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.